News archive
CVX Venture Partners Event – Copenhagen
[MAY 6 2026 at 16:30, Copenhagen, Denmark]
Redeye Diabetes Day – Stockholm
[MAY 6 2026 at 13:15, Stockholm, Sweden]
PILA PHARMA will attend the BIO-Europe Spring Pharma Partnering Conference in Lisbon from March 23–25.
TO2 WARRANTS: Exercise period 05 – 15 February 2026
INVITATION TO LIVE Q&A, REGARDING PRECLINICAL STUDIES AND UPCOMING CLINICAL STUDIES [January 27, 2026]
PILA PHARMA AB (publ) (FN STO: PILA) (“PILA PHARMA” or the “Company”), an innovative biotech company developing a novel oral, small molecule TRPV1 inhibitor, today hosts an online Q&A (questions and answers) in relation to its concluded preclinical studies and upcoming clinical activities.
[January 12–14, 2026]
Biotech Showcase, JP Morgan Healthcare Week, San Francisco, United States.
[PILA PHARMA Corporate Presentation Tuesday, Jan 13 at 11:30AM PT]
